NCT00894777 Study Evaluating Management of Patients With Moderate and Severe Psoriasis Status COMPLETED Phase N/A
NCT00879944 Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index Status COMPLETED Phase N/A
NCT00867100 Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 Status COMPLETED Phase PHASE1
NCT00848055 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis Status COMPLETED Phase PHASE1
NCT00842153 Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam Status COMPLETED Phase PHASE4
NCT00833053 Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315) Status TERMINATED Phase PHASE3
NCT00830817 Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis Status COMPLETED Phase N/A
NCT00824980 Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis Status UNKNOWN Phase PHASE2
NCT00823914 Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life Status COMPLETED Phase N/A
NCT00823693 Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis Status COMPLETED Phase PHASE2
NCT00820950 A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00808223 Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE2
NCT00800982 Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis Status COMPLETED Phase NA
NCT00789880 Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 Status COMPLETED Phase PHASE2